Amylyx Pharmaceuticals (AMLX) Receivables - Net (2022 - 2025)
Historic Receivables - Net for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Q3 2025 value amounting to $132000.0.
- Amylyx Pharmaceuticals' Receivables - Net fell 9237.44% to $132000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $132000.0, marking a year-over-year decrease of 9237.44%. This contributed to the annual value of $447000.0 for FY2024, which is 9888.39% down from last year.
- According to the latest figures from Q3 2025, Amylyx Pharmaceuticals' Receivables - Net is $132000.0, which was down 9237.44% from $103000.0 recorded in Q2 2025.
- In the past 5 years, Amylyx Pharmaceuticals' Receivables - Net registered a high of $40.0 million during Q4 2023, and its lowest value of $103000.0 during Q2 2025.
- Moreover, its 4-year median value for Receivables - Net was $4.1 million (2024), whereas its average is $12.5 million.
- Per our database at Business Quant, Amylyx Pharmaceuticals' Receivables - Net surged by 2132554.74% in 2023 and then crashed by 9888.39% in 2024.
- Quarter analysis of 4 years shows Amylyx Pharmaceuticals' Receivables - Net stood at $15.3 million in 2022, then surged by 161.66% to $40.0 million in 2023, then crashed by 98.88% to $447000.0 in 2024, then crashed by 70.47% to $132000.0 in 2025.
- Its last three reported values are $132000.0 in Q3 2025, $103000.0 for Q2 2025, and $300000.0 during Q1 2025.